EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy

Rachel Sagar, Lilian Walther-Jallow, Anna L David, Cecilia Götherström, Magnus Westgren

Current Stem Cell Reports · 2018-03 · 4 (1) · 61-68

DOI: 10.1007/s40778-018-0118-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Stem Cell Reports, online erschienen am 15.02.2018. Verfasst von Rachel Sagar und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Institute for Women's Health, University College London, 86-96 Chenies Mews, London, WC1E 6HX UK. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: The aim of the study is to provide an overview on the possibility of treating congenital disorders prenatally with mesenchymal stromal cells (MSCs). RECENT FINDINGS: MSCs have multilineage potential and a low immunogenic profile and are immunomodulatory and more easy to expand in culture. Their ability to migrate, engraft and differentiate, or act via a paracrine effect on target tissues makes MSCs candidates for clinical therapies. Fetal and extra-fetal MSCs offer higher therapeutic potential compared to MSCs derived from adult sources. SUMMARY: MSCs may be safely transplanted prenatally via ultrasound-guided injection into the umbilical cord. Due to these characteristics, fetal MSCs are of great interest in the field of in utero stem cell transplantation for treatment of congenital disease.

Schlagwörter

Stichwörter der Autor:innen

In utero stem cell transplantationMesenchymal stromal cellsPrenatal therapy

Autor:innen und Institutionen

  • 1Institute for Women's Health, University College London, 86-96 Chenies Mews, London, WC1E 6HX UK.
  • 2Department of Clinical Science, Intervention and Technology, K57, Division of Obstetrics and Gynecology, Karolinska University Hospital Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden.
  • 3Katholieke Universiteit Leuven, Oude Markt 13, 3000 Leuven, Belgium.

Förderung

  • Karolinska Institute

Zitieren

APA

Sagar, R., Walther-Jallow, L., David, A. L., Götherström, C., & Westgren, M. (2018). Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy. Current Stem Cell Reports, 4(1), 61-68. https://doi.org/10.1007/s40778-018-0118-8

Vancouver

Sagar R, Walther-Jallow L, David AL, Götherström C, Westgren M. Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy. Current Stem Cell Reports. 2018;4(1):61-68. doi:10.1007/s40778-018-0118-8

BibTeX
@article{Sagar2018,
  author = {Sagar, Rachel and Walther-Jallow, Lilian and David, Anna L and Götherström, Cecilia and Westgren, Magnus},
  title = {Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy},
  journal = {Current Stem Cell Reports},
  year = {2018},
  volume = {4},
  number = {1},
  pages = {61--68},
  doi = {10.1007/s40778-018-0118-8}
}
Kostenlos starten →